相关实验视频

Updated: May 23, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

在固体癌症中PARP抑制剂的风景

Marta Muzzana¹, Massimo Broggini², Giovanna Damia²

¹Oncology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

OncoTargets and therapy

|March 7, 2025

概括

多 (ADP-ribose) 聚合酶 (PARP) 抑制剂对具有同源重组 (HR) 缺陷的癌症,包括乳腺癌,卵巢癌,前列腺癌和胰腺癌,显示出有前途. 组合疗法可能会进一步改善患者的生存率.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
遗传学遗传学是一个

背景情况:

在缺乏同源重组 (HR) 的模型中,PARP抑制剂表现出临床前的疗效.
HR缺陷和PARP抑制之间的合成致死性推动了临床试验.
在HR缺陷的乳腺和卵巢癌中观察到显著的反应.

研究的目的:

审查PARP抑制剂 (PARPi) 在HR缺陷的固体瘤中的疗效.
探索PARPi与其他治疗剂结合的潜力.

主要方法:

对各种固体瘤中PARPi的临床试验数据的审查.
对PARP抑制和HR缺陷的临床前研究的分析.
评估涉及PARPi的组合治疗策略.

主要成果:

在HR缺陷的乳腺,卵巢,前列腺和胰腺癌中,PARPi已经显示出显著的反应.
现在有几种PARP抑制剂在临床上可用.
组合疗法,包括免疫检查点抑制剂,显示出改善生存的潜力.

结论:

PARP 抑制剂是HR缺乏固体瘤的有效治疗方法.
将PARPi扩展到前列腺癌和胰腺癌的使用得到了临床数据的支持.
组合策略有望提高患者的治疗结果.

关键词:

这就是BRCA BRCA.造成的DNA损伤是DNA损伤.这是一种PARP抑制剂.同类的重组组合.固体瘤是一种固体瘤.

更多相关视频

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells

Published on: August 21, 2013

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...